NabGen Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
4
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$3M
- Investors
-
3
NabGen General Information
Description
Operator of a biotechnology company developing a novel strategy to block AAV-neutralizing universal antibody suppressant as a therapeutic to inhibit anti-drug antibodies,anti-transplant antibodies, and treat autoimmune disease. The company's platform technology functions as a universal antibody suppressant to inhibit anti-drug antibodies, and anti-transplant antibodies, and treat autoimmune disease and offers a strategy to block AAV (adeno-associated virus)-neutralizing antibody activity and re-administration barriers of gene therapies based on adeno-associated virus AAV vectors, enabling doctors to unlock the full potential of cutting-edge treatments for patients with rare diseases.
Contact Information
Website
www.nabgen.comCorporate Office
- 6 Davis Drive
- Durham, NC 27709
- United States
Corporate Office
- 6 Davis Drive
- Durham, NC 27709
- United States
NabGen Timeline
NabGen Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Grant | 15-Aug-2025 | $3M | Completed | Generating Revenue | ||
| 5. Grant | 31-Mar-2023 | Completed | Generating Revenue | |||
| 4. Early Stage VC | 10-Mar-2022 | Completed | Startup | |||
| 3. Debt - General | 29-Jul-2021 | Completed | Startup | |||
| 2. Grant | 31-Jul-2020 | $300K | $30K | Completed | Startup | |
| 1. Accelerator/Incubator | 21-May-2020 | $30K | $30K | Completed | Startup |
NabGen Comparisons
Industry
Financing
Details
NabGen Competitors (3)
One of NabGen’s 3 competitors is Hansa Biopharma, a Corporation company based in Lund, Sweden.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Hansa Biopharma | Corporation | Lund, Sweden | ||||
| Selecta Biosciences | Formerly VC-backed | Watertown, MA | ||||
| Argenx | Formerly VC-backed | Zwijnaarde, Belgium |
NabGen Signals
NabGen Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| National Center For Advancing Translational Sciences | Government | |||
| National Institute Of Allergy and Infectious Diseases | Government | |||
| KickStart Venture Services | Accelerator/Incubator |
NabGen FAQs
-
When was NabGen founded?
NabGen was founded in 2019.
-
Where is NabGen headquartered?
NabGen is headquartered in Durham, NC.
-
What is the size of NabGen?
NabGen has 4 total employees.
-
What industry is NabGen in?
NabGen’s primary industry is Drug Discovery.
-
Is NabGen a private or public company?
NabGen is a Private company.
-
What is NabGen’s current revenue?
The current revenue for NabGen is .
-
How much funding has NabGen raised over time?
NabGen has raised $780K.
-
Who are NabGen’s investors?
National Center For Advancing Translational Sciences, National Institute Of Allergy and Infectious Diseases, and KickStart Venture Services have invested in NabGen.
-
Who are NabGen’s competitors?
Hansa Biopharma, Selecta Biosciences, and Argenx are competitors of NabGen.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process